2027 Bio-Medical Technology Development Project (Next-Generation Target Protein Degradation Synthetic Drug Development Support Platform Construction) New Joint Research Project Call
A platform construction project for next-generation target protein degradation drug development with up to 100% government support.
- Deadline
- 마감일 원문 확인
This project supports R&D to derive lead compounds in the field of next-generation target protein degradation and control through structural optimization and stepwise validation. Institutional burden ratios for research costs and cash contributions vary according to the government support percentage.
3-second summary
- Lead Agency: National Research Foundation of Korea
- Support Content: Structural optimization and lead compound derivation for effective substances in next-generation target protein degradation and control
- Cost Sharing: Government support 50-100% or less, Institutional burden 25-50% or more
Recommended for
- Recommended for joint research consortia capable of developing synthetic drugs based on next-generation target protein degradation and control technology.
Frequently asked questions
How do I apply?
Applications follow the official program notice, which is in Korean. See the source link for the method and receiving office; Beaconoi can prepare an English draft for your review.
Which organization runs this program?
This program is administered by National Research Foundation of Korea.
Last updated · Source: National Research Foundation of Korea — official notice
※ Program information is compiled from each institution’s public sources; actual eligibility, amounts and deadlines may change. Always verify against the official notice (in Korean) before applying.